SEI Investments’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.72M Sell
123,214
-11,685
-9% -$420K 0.01% 1430
2026
Q1
$3.31M Buy
134,899
+65,509
+94% +$1.55M ﹤0.01% 1769
2025
Q4
$1.72M Buy
69,390
+52,723
+316% +$1.4M ﹤0.01% 1931
2025
Q3
$473K Buy
16,667
+5,507
+49% +$149K ﹤0.01% 2256
2025
Q2
$278K Buy
11,160
+2,700
+32% +$76K ﹤0.01% 2444
2025
Q1
$262K Sell
8,460
-9,798
-54% -$326K ﹤0.01% 2391
2024
Q4
$576K Sell
18,258
-5,461
-23% -$259K ﹤0.01% 2138
2024
Q3
$1.37M Buy
23,719
+1,183
+5% +$58.1K ﹤0.01% 1843
2024
Q2
$914K Buy
+22,536
New +$894K ﹤0.01% 1944

Other funds holding ASTH

SEI Investments's ASTH Position: Q2 2026 in Review

SEI Investments reduced its Astrana Health (ASTH) stake by 8.7% in Q2 2026, selling an estimated $420K and leaving 123,214 shares worth $5.72M. The position accounts for 0.01% of the portfolio, ranked #1430.

SEI Investments first reported a position in ASTH in Q2 2024 and has held it in 9 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • SEI Investments held 123,214 shares of Astrana Health worth $5.72M as of Q2 2026.
  • SEI Investments sold 11,685 Astrana Health shares in Q2 2026, an estimated $420K.
  • Astrana Health made up 0.01% of SEI Investments's portfolio in Q2 2026, its #1430 holding.
  • SEI Investments first reported a position in Astrana Health in Q2 2024 and has held it in 9 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.